(Q37187033)

18 August 2017

The effect of continuous versus pericycle antiretroviral therapy on IL-2 responsiveness (English)

1 reference

18 August 2017

anti-retroviral agent

0 references

Irini Sereti

9

0 references

Joseph W Adelsberger

4

object named as

Joseph Adelsberger

1 reference

18 August 2017

Letha M Healey

1

1 reference

18 August 2017

Barbara K Hahn

2

1 reference

18 August 2017

Catherine A Rehm

3

1 reference

18 August 2017

Jing Qin

5

1 reference

18 August 2017

Dean A Follmann

6

1 reference

18 August 2017

Jorge Tavel

7

1 reference

18 August 2017

Joseph A Kovacs

8

1 reference

18 August 2017

Richard T Davey

10

1 reference

18 August 2017

1 July 2008

1 reference

Journal of Interferon and Cytokine Research

18 August 2017

1 reference

18 August 2017

28

1 reference

18 August 2017

7

1 reference

18 August 2017

455-462

1 reference

Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trials

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680163

A randomised trial of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients: the UK-Vanguard Study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680163

Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680163

In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680163

Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680163

IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680163

Cytokine-based therapies for HIV infection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680163

Random-effects models for longitudinal data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680163

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680163

Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680163

A Pilot Study Evaluating Time to CD4 T-cell Count <350 cells/mm3 After Treatment Interruption Following Antiretroviral Therapy ± Interleukin 2: Results of ACTG A5102

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680163

Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680163

Complications of HIV disease and antiretroviral therapy

4 December 2018

1 reference

12 December 2020

Interleukin 2 treatment in HIV-1 infection

1 reference

12 December 2020

Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients

1 reference

12 December 2020

Immunomodulators as adjunctive therapy for HIV-1 infection

1 reference

12 December 2020

Identifiers

DOI

10.1089/JIR.2007.0120

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

18597618

1 reference